Document is current
Any future updates will be listed below
-
Authors
Larsen, Eigil Lindekilde
Ashina, Håkan
Iljazi, Afrim
Al-Khazali, Haidar Muhsen
Seem, Kristoffer
Ashina, Messoud
Ashina, Sait
Schytz, Henrik Winther https://orcid.org/0000-0002-6262-2986
- License Information
-
More Information
Article History
Received: 18 July 2019
Accepted: 2 October 2019
First Online: 21 October 2019
Ethics approval and consent to participate
: Not Applicable.
: Not Applicable.
: HWS received speaking fees from Novartis and Teva. SA has received honoraria from Allergan and Teva and consultant fees from Amgen and Allergan. SA received honoraria for lecturing from Allergan and Avanir Pharmaceuticals. MA has received personal fees from Alder BioPharmaceuticals, Allergan, Amgen, Eli Lilly, Novartis, and Teva. MA also participated in clinical trials as the principal investigator for Alder, Amgen, electroCore, Novartis, and Teva. MA also serves as an associate editor of Cephalalgia, associate editor of Headache and co-editor of the Journal of Headache and Pain. MA is President-elect of the International Headache Society, and General Secretary of the European Headache Federation. MA reports research grants from Lundbeck Foundation, Research Foundation of the Capital Region of Copenhagen, and Novo Nordisk Foundation. The other authors declare no conflicts of interest.
